Nosto lands $17 Million to own Ecommerce Personalization
Nosto, the industry leading personalization software solution for online retailers, has secured $17 million in funding from the European Investment Bank, which will be used to accelerate Nosto’s continuous product innovation and research program and to fuel Nosto’s expansion within the US and EMEA regions, as well as entry into new markets. This will enable the development of more innovative features using Nosto’s cutting-edge patented technology to help retailers grow their businesses with strong local support by skilled professionals.
This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20170713005374/en/
Nosto Lands $17 Million to Own Ecommerce Personalization (Photo: Business Wire)
“We have developed a breakthrough SaaS platform that makes it easy for retailers to deliver personalized shopping experiences to every individual across all touchpoints. This is an exciting stage in our company’s growth and we’ll continue to focus our capital and energy on building a great product to empower retailers to succeed. This funding allows us to further innovate and continue our mission of connecting people with products across their entire shopping journey,” says Juha Valvanne, one of the founders of Nosto.
With the mission of making it easy for retailers to deliver their customers personalized shopping experiences, at every touch point, across every device, Nosto offers its multi-channel online personalization solution for online retailers worldwide, aiming to create a fully personalized customer journey through the use of real-time, targeted product recommendations.
By analyzing hundreds of thousands of data points in online stores to build a deep understanding of every customer in real-time, Nosto’s patented technology empowers retailers to deliver the right product ads to the right users at the right time through personalized product recommendations on websites, mobile apps, emails and social ads.
Nosto has forged strong partnerships with top level ecommerce platforms such as Magento and Shopify Plus, ensuring high quality service for its customers. As of April 2017 Nosto also became an official Facebook Marketing Partner, joining an exclusive group of companies known for their excellence on the platform. The customer base includes leading brands such as Twinings, Jack Daniels, Everlast and Volcom.
"The funding will help us grow our operations and introduce our cutting-edge patented technology to new markets. We will use the funding to keep attracting even more talents to our international team as well as investing in our personnel and product development. All of this will fuel our worldwide growth and expansion even further. Our aim is to be the global leader in ecommerce personalization," says Matti Rönkkö, CEO of Nosto.
The loan is one of the largest that has been provided to a startup company by the European Fund for Strategic Investments (EFSI), a joint initiative of the European Investment Bank and European Commission.
European Commission Vice-President Jyrki Katainen, responsible for Jobs, Growth, Investment and Competitiveness, said: “Global expansion and developing innovative products demands investment. Investing in research is a critical factor in ensuring that European companies, such as Nosto, maintain their status as innovation leaders in e-commerce when competing in the global marketplace. I am delighted that the European Fund for Strategic Investments is playing an important role in facilitating such investments.”
In addition to EIB, the company is backed by investors such as Wellington Partners and Open Ocean Capital. The resources provided will aid in Nosto’s growth plans, which include hiring engineers to the Nosto headquarter located in Helsinki and increasing its sales and marketing teams in New York, London, Stockholm and Berlin. Additionally, Nosto will open its Los Angeles office in the fall to strengthen its support in the US market and will be recruiting skilled professionals.
Nosto enables online retailers to deliver their customers personalized shopping experiences at every touch point, across every device. A powerful personalization solution designed for ease of use, Nosto empowers retailers to build, launch and optimize 1:1 multi-channel marketing campaigns without the need for dedicated IT resources. Leading retail brands in over 100 countries use Nosto to grow their business and delight their customers. Nosto supports its retailers from its offices in Helsinki, Berlin, Stockholm, London and New York.
Tel.: +49 176 61 98 68 29
Om Business Wire
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Følg saker fra Business Wire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Business Wire
New Data Show Benefit of Tagrisso in Patients with EGFR-mutated Non-small Cell Lung Cancer and Central Nervous System Metastases18.11.2017 23:00 | Pressemelding
AstraZeneca today presented new data from a subgroup analysis of the Phase III FLAURA trial, which explored osimertinib as 1st-line therapy in patients with locally advanced or metastatic epidermal growth factor receptor (EGFR) mutation-positive non-small cell lung cancer (NSCLC). Results presented at the ESMO Asia 2017 Congress in Singapore showed that patients with central nervous system (CNS) metastases at baseline had a higher objective response rate with their brain metastasis and suggest a lower risk of CNS progression when treated with osimertinib, a third-generation, irreversible EGFR tyrosine kinase inhibitor (TKI), versus current standard-of-care EGFR-TKIs (erlotinib or gefitinib) [Abstract LBA5].1 The analysis included patients with ≥1 measurable and/or non-measurable CNS lesion present on baseline scan (as assessed by blinded independent central review), accounting for 23
New England Journal of Medicine Publishes Results of Phase III FLAURA Trial in the 1st-Line Treatment of EGFR-mutated Non-small Cell Lung Cancer18.11.2017 18:20 | Pressemelding
AstraZeneca today announced that the New England Journal of Medicine has published the positive results from the Phase III FLAURA trial which provide data for Tagrisso’s (osimertinib) use in the 1st-line treatment of adult patients with locally advanced or metastatic epidermal growth factor receptor (EGFR)-mutated non-small cell lung cancer (NSCLC).1 The trial showed a statistically significant, clinically meaningful progression-free survival (PFS) advantage for osimertinib, a third-generation, irreversible EGFR tyrosine kinase inhibitor (TKI), compared with current 1st-line EGFR-TKIs, erlotinib or gefitinib.1 This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171118005044/en/ Dr. Suresh S. Ramalingam, Principal Investigator of the FLAURA trial, from the Winship Cancer Institute
Much-Anticipated CHTF 2017 Top 10 Products Are Unveiled18.11.2017 09:11 | Pressemelding
The 19th China Hi-Tech Fair (CHTF 2017), with the theme of “Innovation-Driven Development and Supply Quality Upgrade”, is taking place from November 16 to 21 at Shenzhen Convention and Exhibition Center. On the afternoon of November 10, the CHTF 2017 Top 10 Products were unveiled at the awards ceremony by Mr. Gao Zimin, Vice Mayor of Shenzhen City. A total of 322 entries competed for the honor Top 10 Products, and the voting lasted nearly 3 months. 60 candidate products in the fields of new energy, 3D print, flexible display, life sciences, unmanned vehicles and AI were shortlisted by the organizer, experts and media representatives and went for open voting online. The final Top 10 Products all represent the most advanced technologies in their respective sectors: the water-making device that can make water out of air, the smart sportswear that can monitor heartbeat and other
Madison Realty Capital Provides $64.0 Million Construction Financing for 200 Kent Avenue Development in Williamsburg, Brooklyn17.11.2017 16:20 | Pressemelding
Madison Realty Capital (MRC) announced the closing of a $64.0 million construction loan for 200 Kent Avenue, a 117,326 square foot mixed-use development located in Williamsburg, Brooklyn. The retail portion of the property, which will include over 600 feet of frontage, will be anchored by a popular national grocery chain. Overall, the project will offer 50,101 square feet of retail space, 22,055 square feet of office and restaurant space, and 45,170 square feet of parking. “We continue to establish MRC as the one-stop shop for financing transitional real estate, including ground-up development deals like 200 Kent Avenue,” said Josh Zegen, Co-Founder and Managing Principal of MRC. “In this case, we’re working with a repeat MRC borrower who understands our ability to execute efficiently, given our firm’s up-to-the minute knowledge of local market conditions and non-bureaucratic approach to
Ncardia Announces Completion of €10.5M Investment Round17.11.2017 12:31 | Pressemelding
Ncardia, an emerging drug discovery and development stem cell technology company whose mission is to deliver cardiac and neural solutions based on its best-in-class human induced pluripotent stem cell (iPSC)-derived technology, today announced the completion of a €10.5 million series B financing round. The round was led by Épimède, a Belgium venture capital firm. Ncardia is a privately-held company with operations in Europe and the US, that produces and commercializes high-quality, fully-functional human iPSC-derived cardiovascular and neuronal cell types. Using its cell products, Ncardia develops and commercializes assay services for drug safety and efficacy testing. Additionally the company has built up a strong portfolio of patents covering the use of stem cell models for these applications. Stefan Braam, CEO of Ncardia, commented: “At Ncardia, important progress h
Double Win for Vocalink at the 2017 Payments Awards17.11.2017 09:35 | Pressemelding
Vocalink, a Mastercard company, was last night awarded with two prestigious awards - The Overall Winner and the Payments Infrastructure of the Year Award, for its leading technology and expertise, and in recognition for a milestone year that saw Vocalink’s solutions transform the way people and businesses move money across the globe. 2017 saw Vocalink deliver ground-breaking immediate payments solutions both in the US and Thailand as well as enabling access to the UK payments industry through their payments gateway solution PayPort. The business also saw the launch of the new image based cheque clearing system, creating a robust and more efficient system in the UK. RTP ® in the US: This week, Vocalink announced the launch of RTP® (Real-Time Payments) in the US on behalf of The Clearing House; one of the most comprehensive real-tim
I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.Besøk vårt presserom